Targeting kidney mesangium by nanoparticles of defined size

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 16, 2011, Pages 6656-6661

  Choi, Chung Hang J ^a   Zuckerman, Jonathan E ^a   Webster, Paul ^b   Davis, Mark E ^a  

^a California Institute of Technology   (United States)

^b HOUSE EAR INSTITUTE   (United States)

Author keywords

Gold nanoparticles; Kidney targeting; Mesangial cells; Particle size

Indexed keywords

GOLD NANOPARTICLE; MACROGOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; KIDNEY; MESANGIUM; MOUSE; NONHUMAN; ORGAN DISTRIBUTION; PARTICLE SIZE; PRIORITY JOURNAL;

ANIMALS; DRUG DELIVERY SYSTEMS; FEMALE; GLOMERULAR MESANGIUM; GOLD; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; PARTICLE SIZE;

EID: 79955609960     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1103573108     Document Type: Article

References (18)

1. Davis ME, Chen ZG, Shin DM (2008) Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat Rev Drug Discov 7:771-782.
2. Peer D, et al. (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751-760. (Pubitemid 350223348)
3. Davis ME (2009) The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: From concept to clinic. Mol Pharm 6:659-668.
4. Zimmermann TS, et al. (2006) RNAi-mediated gene silencing in non-human primates. Nature 441:111-114.
5. Choi HS, et al. (2007) Renal clearance of quantum dots. Nat Biotechnol 25:1165-1170.
6. Choi HS, et al. (2009) Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots. Nano Lett 9:2354-2359.
7. Luft FC, et al. (1982) Effects of moxalactam and cefotaxime on rabbit renal tissue. Antimicrob Agents Chemother 21:830-835. (Pubitemid 12006537)
8. Kanwar YS, Farquhar MG (1979) Presence of heparan sulfate in the glomerular basement membrane. Proc Natl Acad Sci USA 76:1303-1307. (Pubitemid 9143728)
9. Ogawa S, et al. (1999) High-resolution ultrastructural comparison of renal glomerular and tubular basement membranes. Am J Nephrol 19:686-693.
10. Lahdenkari A-T, et al. (2004) Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol 15:2611-2618. (Pubitemid 41103367)
11. Tan M, et al. (2010) An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix. Mol Pharm 7:936-943.
12. Schipper ML, et al. (2009) Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 5:126-134.
13. L'Azou B, et al. (2008) In vitro effects of nanoparticles on renal cells. Part Fibre Toxicol 5:1-14.
14. Chen Z, et al. (2006) Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett 163:109-120.
15. Dan N, Tirrell M (1992) Polymers tethered to curved interfaces. A self-consistent-field analysis. Macromolecules 25:2890-2895.
16. Sadauskas E, et al. (2007) Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 4:1-7.
17. Schreiner GF (1992) The mesangial phagocyte and its regulation of contractile cell biology. J Am Soc Nephrol 2:S74-S82.
18. Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME (2007) Impact of tumorspecific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA 104:15549-15554. (Pubitemid 47502954)